img

Global Osteoarthritis Medications Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Osteoarthritis Medications Market Insights, Forecast to 2034

Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.
Market Analysis and InsightsGlobal Osteoarthritis Medications Market
The global Osteoarthritis Medications market is projected to grow from US$ 9599.7 million in 2024 to US$ 11730 million by 2034, at a Compound Annual Growth Rate (CAGR) of 3.4% during the forecast period.
North America is the largest Drugs for Osteoarthritis Pain market with about 36% market share. Europe is follower, accounting for about 27% market share.
The key players are Pfizer, Johnson & Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma, Abbott, Mylan, Daiichi Sankyo, TEVA, Almatica Pharma, Astellas Pharma, Tide Pharmaceutical, Iroko Pharmaceuticals, Hengrui Pharmaceutical, Abiogen Pharma etc. Top 5 companies occupied about 66% market share.
Report Includes
This report presents an overview of global market for Osteoarthritis Medications market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2024, and projections of CAGR through 2034.
This report researches the key producers of Osteoarthritis Medications, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Osteoarthritis Medications, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Osteoarthritis Medications revenue, market share and industry ranking of main companies, data from 2018 to 2024. Identification of the major stakeholders in the global Osteoarthritis Medications market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2034. Evaluation and forecast the market size for Osteoarthritis Medications revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, Bayer, Eli Lilly, Sanofi, Horizon Pharma and Abbott, etc.



By Company


Pfizer
Johnson & Johnson
GlaxoSmithKline
Novartis
Bayer
Eli Lilly
Sanofi
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma
Flexion Therapeutics
Anika Therapeutics
Segment by Type
NSAIDs
Corticosteroids
Hyaluronic Acid Injection
Others

Segment by Application


Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Revenue of Osteoarthritis Medications in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3Detailed analysis of Osteoarthritis Medications companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8China by type and by application revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Osteoarthritis Medications revenue, gross margin, and recent development, etc.
Chapter 12Analyst's Viewpoints/Conclusions

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Osteoarthritis Medications Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 NSAIDs
1.2.3 Corticosteroids
1.2.4 Hyaluronic Acid Injection
1.2.5 Others
1.3 Market by Application
1.3.1 Global Osteoarthritis Medications Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Osteoarthritis Medications Market Perspective (2018-2034)
2.2 Global Osteoarthritis Medications Growth Trends by Region
2.2.1 Osteoarthritis Medications Market Size by Region: 2018 VS 2022 VS 2034
2.2.2 Osteoarthritis Medications Historic Market Size by Region (2018-2024)
2.2.3 Osteoarthritis Medications Forecasted Market Size by Region (2024-2034)
2.3 Osteoarthritis Medications Market Dynamics
2.3.1 Osteoarthritis Medications Industry Trends
2.3.2 Osteoarthritis Medications Market Drivers
2.3.3 Osteoarthritis Medications Market Challenges
2.3.4 Osteoarthritis Medications Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Osteoarthritis Medications by Players
3.1.1 Global Osteoarthritis Medications Revenue by Players (2018-2024)
3.1.2 Global Osteoarthritis Medications Revenue Market Share by Players (2018-2024)
3.2 Global Osteoarthritis Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Osteoarthritis Medications, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Osteoarthritis Medications Market Concentration Ratio
3.4.1 Global Osteoarthritis Medications Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Osteoarthritis Medications Revenue in 2022
3.5 Global Key Players of Osteoarthritis Medications Head office and Area Served
3.6 Global Key Players of Osteoarthritis Medications, Product and Application
3.7 Global Key Players of Osteoarthritis Medications, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Osteoarthritis Medications Breakdown Data by Type
4.1 Global Osteoarthritis Medications Historic Market Size by Type (2018-2024)
4.2 Global Osteoarthritis Medications Forecasted Market Size by Type (2024-2034)
5 Osteoarthritis Medications Breakdown Data by Application
5.1 Global Osteoarthritis Medications Historic Market Size by Application (2018-2024)
5.2 Global Osteoarthritis Medications Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Osteoarthritis Medications Market Size (2018-2034)
6.2 North America Osteoarthritis Medications Market Size by Type
6.2.1 North America Osteoarthritis Medications Market Size by Type (2018-2024)
6.2.2 North America Osteoarthritis Medications Market Size by Type (2024-2034)
6.2.3 North America Osteoarthritis Medications Market Share by Type (2018-2034)
6.3 North America Osteoarthritis Medications Market Size by Application
6.3.1 North America Osteoarthritis Medications Market Size by Application (2018-2024)
6.3.2 North America Osteoarthritis Medications Market Size by Application (2024-2034)
6.3.3 North America Osteoarthritis Medications Market Share by Application (2018-2034)
6.4 North America Osteoarthritis Medications Market Size by Country
6.4.1 North America Osteoarthritis Medications Market Size by Country: 2018 VS 2022 VS 2034
6.4.2 North America Osteoarthritis Medications Market Size by Country (2018-2024)
6.4.3 North America Osteoarthritis Medications Market Size by Country (2024-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Osteoarthritis Medications Market Size (2018-2034)
7.2 Europe Osteoarthritis Medications Market Size by Type
7.2.1 Europe Osteoarthritis Medications Market Size by Type (2018-2024)
7.2.2 Europe Osteoarthritis Medications Market Size by Type (2024-2034)
7.2.3 Europe Osteoarthritis Medications Market Share by Type (2018-2034)
7.3 Europe Osteoarthritis Medications Market Size by Application
7.3.1 Europe Osteoarthritis Medications Market Size by Application (2018-2024)
7.3.2 Europe Osteoarthritis Medications Market Size by Application (2024-2034)
7.3.3 Europe Osteoarthritis Medications Market Share by Application (2018-2034)
7.4 Europe Osteoarthritis Medications Market Size by Country
7.4.1 Europe Osteoarthritis Medications Market Size by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Osteoarthritis Medications Market Size by Country (2018-2024)
7.4.3 Europe Osteoarthritis Medications Market Size by Country (2024-2034)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Osteoarthritis Medications Market Size (2018-2034)
8.2 China Osteoarthritis Medications Market Size by Type
8.2.1 China Osteoarthritis Medications Market Size by Type (2018-2024)
8.2.2 China Osteoarthritis Medications Market Size by Type (2024-2034)
8.2.3 China Osteoarthritis Medications Market Share by Type (2018-2034)
8.3 China Osteoarthritis Medications Market Size by Application
8.3.1 China Osteoarthritis Medications Market Size by Application (2018-2024)
8.3.2 China Osteoarthritis Medications Market Size by Application (2024-2034)
8.3.3 China Osteoarthritis Medications Market Share by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Osteoarthritis Medications Market Size (2018-2034)
9.2 Asia Osteoarthritis Medications Market Size by Type
9.2.1 Asia Osteoarthritis Medications Market Size by Type (2018-2024)
9.2.2 Asia Osteoarthritis Medications Market Size by Type (2024-2034)
9.2.3 Asia Osteoarthritis Medications Market Share by Type (2018-2034)
9.3 Asia Osteoarthritis Medications Market Size by Application
9.3.1 Asia Osteoarthritis Medications Market Size by Application (2018-2024)
9.3.2 Asia Osteoarthritis Medications Market Size by Application (2024-2034)
9.3.3 Asia Osteoarthritis Medications Market Share by Application (2018-2034)
9.4 Asia Osteoarthritis Medications Market Size by Region
9.4.1 Asia Osteoarthritis Medications Market Size by Region: 2018 VS 2022 VS 2034
9.4.2 Asia Osteoarthritis Medications Market Size by Region (2018-2024)
9.4.3 Asia Osteoarthritis Medications Market Size by Region (2024-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Osteoarthritis Medications Market Size (2018-2034)
10.2 Middle East, Africa, and Latin America Osteoarthritis Medications Market Size by Type
10.2.1 Middle East, Africa, and Latin America Osteoarthritis Medications Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Osteoarthritis Medications Market Size by Type (2024-2034)
10.2.3 Middle East, Africa, and Latin America Osteoarthritis Medications Market Share by Type (2018-2034)
10.3 Middle East, Africa, and Latin America Osteoarthritis Medications Market Size by Application
10.3.1 Middle East, Africa, and Latin America Osteoarthritis Medications Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Osteoarthritis Medications Market Size by Application (2024-2034)
10.3.3 Middle East, Africa, and Latin America Osteoarthritis Medications Market Share by Application (2018-2034)
10.4 Middle East, Africa, and Latin America Osteoarthritis Medications Market Size by Country
10.4.1 Middle East, Africa, and Latin America Osteoarthritis Medications Market Size by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa, and Latin America Osteoarthritis Medications Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Osteoarthritis Medications Market Size by Country (2024-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Osteoarthritis Medications Introduction
11.1.4 Pfizer Revenue in Osteoarthritis Medications Business (2018-2024)
11.1.5 Pfizer Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Osteoarthritis Medications Introduction
11.2.4 Johnson & Johnson Revenue in Osteoarthritis Medications Business (2018-2024)
11.2.5 Johnson & Johnson Recent Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Osteoarthritis Medications Introduction
11.3.4 GlaxoSmithKline Revenue in Osteoarthritis Medications Business (2018-2024)
11.3.5 GlaxoSmithKline Recent Developments
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Osteoarthritis Medications Introduction
11.4.4 Novartis Revenue in Osteoarthritis Medications Business (2018-2024)
11.4.5 Novartis Recent Developments
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Business Overview
11.5.3 Bayer Osteoarthritis Medications Introduction
11.5.4 Bayer Revenue in Osteoarthritis Medications Business (2018-2024)
11.5.5 Bayer Recent Developments
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Osteoarthritis Medications Introduction
11.6.4 Eli Lilly Revenue in Osteoarthritis Medications Business (2018-2024)
11.6.5 Eli Lilly Recent Developments
11.7 Sanofi
11.7.1 Sanofi Company Details
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Osteoarthritis Medications Introduction
11.7.4 Sanofi Revenue in Osteoarthritis Medications Business (2018-2024)
11.7.5 Sanofi Recent Developments
11.8 Horizon Pharma
11.8.1 Horizon Pharma Company Details
11.8.2 Horizon Pharma Business Overview
11.8.3 Horizon Pharma Osteoarthritis Medications Introduction
11.8.4 Horizon Pharma Revenue in Osteoarthritis Medications Business (2018-2024)
11.8.5 Horizon Pharma Recent Developments
11.9 Abbott
11.9.1 Abbott Company Details
11.9.2 Abbott Business Overview
11.9.3 Abbott Osteoarthritis Medications Introduction
11.9.4 Abbott Revenue in Osteoarthritis Medications Business (2018-2024)
11.9.5 Abbott Recent Developments
11.10 Mylan
11.10.1 Mylan Company Details
11.10.2 Mylan Business Overview
11.10.3 Mylan Osteoarthritis Medications Introduction
11.10.4 Mylan Revenue in Osteoarthritis Medications Business (2018-2024)
11.10.5 Mylan Recent Developments
11.11 Daiichi Sankyo
11.11.1 Daiichi Sankyo Company Details
11.11.2 Daiichi Sankyo Business Overview
11.11.3 Daiichi Sankyo Osteoarthritis Medications Introduction
11.11.4 Daiichi Sankyo Revenue in Osteoarthritis Medications Business (2018-2024)
11.11.5 Daiichi Sankyo Recent Developments
11.12 TEVA
11.12.1 TEVA Company Details
11.12.2 TEVA Business Overview
11.12.3 TEVA Osteoarthritis Medications Introduction
11.12.4 TEVA Revenue in Osteoarthritis Medications Business (2018-2024)
11.12.5 TEVA Recent Developments
11.13 Almatica Pharma
11.13.1 Almatica Pharma Company Details
11.13.2 Almatica Pharma Business Overview
11.13.3 Almatica Pharma Osteoarthritis Medications Introduction
11.13.4 Almatica Pharma Revenue in Osteoarthritis Medications Business (2018-2024)
11.13.5 Almatica Pharma Recent Developments
11.14 Astellas Pharma
11.14.1 Astellas Pharma Company Details
11.14.2 Astellas Pharma Business Overview
11.14.3 Astellas Pharma Osteoarthritis Medications Introduction
11.14.4 Astellas Pharma Revenue in Osteoarthritis Medications Business (2018-2024)
11.14.5 Astellas Pharma Recent Developments
11.15 Tide Pharmaceutical
11.15.1 Tide Pharmaceutical Company Details
11.15.2 Tide Pharmaceutical Business Overview
11.15.3 Tide Pharmaceutical Osteoarthritis Medications Introduction
11.15.4 Tide Pharmaceutical Revenue in Osteoarthritis Medications Business (2018-2024)
11.15.5 Tide Pharmaceutical Recent Developments
11.16 Iroko Pharmaceuticals
11.16.1 Iroko Pharmaceuticals Company Details
11.16.2 Iroko Pharmaceuticals Business Overview
11.16.3 Iroko Pharmaceuticals Osteoarthritis Medications Introduction
11.16.4 Iroko Pharmaceuticals Revenue in Osteoarthritis Medications Business (2018-2024)
11.16.5 Iroko Pharmaceuticals Recent Developments
11.17 Hengrui Pharmaceutical
11.17.1 Hengrui Pharmaceutical Company Details
11.17.2 Hengrui Pharmaceutical Business Overview
11.17.3 Hengrui Pharmaceutical Osteoarthritis Medications Introduction
11.17.4 Hengrui Pharmaceutical Revenue in Osteoarthritis Medications Business (2018-2024)
11.17.5 Hengrui Pharmaceutical Recent Developments
11.18 Abiogen Pharma
11.18.1 Abiogen Pharma Company Details
11.18.2 Abiogen Pharma Business Overview
11.18.3 Abiogen Pharma Osteoarthritis Medications Introduction
11.18.4 Abiogen Pharma Revenue in Osteoarthritis Medications Business (2018-2024)
11.18.5 Abiogen Pharma Recent Developments
11.19 Flexion Therapeutics
11.19.1 Flexion Therapeutics Company Details
11.19.2 Flexion Therapeutics Business Overview
11.19.3 Flexion Therapeutics Osteoarthritis Medications Introduction
11.19.4 Flexion Therapeutics Revenue in Osteoarthritis Medications Business (2018-2024)
11.19.5 Flexion Therapeutics Recent Developments
11.20 Anika Therapeutics
11.20.1 Anika Therapeutics Company Details
11.20.2 Anika Therapeutics Business Overview
11.20.3 Anika Therapeutics Osteoarthritis Medications Introduction
11.20.4 Anika Therapeutics Revenue in Osteoarthritis Medications Business (2018-2024)
11.20.5 Anika Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Osteoarthritis Medications Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2034
Table 2. Key Players of NSAIDs
Table 3. Key Players of Corticosteroids
Table 4. Key Players of Hyaluronic Acid Injection
Table 5. Key Players of Others
Table 6. Global Osteoarthritis Medications Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2034
Table 7. Global Osteoarthritis Medications Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 8. Global Osteoarthritis Medications Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Osteoarthritis Medications Market Share by Region (2018-2024)
Table 10. Global Osteoarthritis Medications Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 11. Global Osteoarthritis Medications Market Share by Region (2024-2034)
Table 12. Osteoarthritis Medications Market Trends
Table 13. Osteoarthritis Medications Market Drivers
Table 14. Osteoarthritis Medications Market Challenges
Table 15. Osteoarthritis Medications Market Restraints
Table 16. Global Osteoarthritis Medications Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Osteoarthritis Medications Revenue Share by Players (2018-2024)
Table 18. Global Top Osteoarthritis Medications by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteoarthritis Medications as of 2022)
Table 19. Global Osteoarthritis Medications Industry Ranking 2021 VS 2022 VS 2024
Table 20. Global 5 Largest Players Market Share by Osteoarthritis Medications Revenue (CR5 and HHI) & (2018-2024)
Table 21. Global Key Players of Osteoarthritis Medications, Headquarters and Area Served
Table 22. Global Key Players of Osteoarthritis Medications, Product and Application
Table 23. Global Key Players of Osteoarthritis Medications, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Osteoarthritis Medications Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Osteoarthritis Medications Revenue Market Share by Type (2018-2024)
Table 27. Global Osteoarthritis Medications Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 28. Global Osteoarthritis Medications Revenue Market Share by Type (2024-2034)
Table 29. Global Osteoarthritis Medications Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Osteoarthritis Medications Revenue Share by Application (2018-2024)
Table 31. Global Osteoarthritis Medications Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 32. Global Osteoarthritis Medications Revenue Share by Application (2024-2034)
Table 33. North America Osteoarthritis Medications Market Size by Type (2018-2024) & (US$ Million)
Table 34. North America Osteoarthritis Medications Market Size by Type (2024-2034) & (US$ Million)
Table 35. North America Osteoarthritis Medications Market Size by Application (2018-2024) & (US$ Million)
Table 36. North America Osteoarthritis Medications Market Size by Application (2024-2034) & (US$ Million)
Table 37. North America Osteoarthritis Medications Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 38. North America Osteoarthritis Medications Market Size by Country (2018-2024) & (US$ Million)
Table 39. North America Osteoarthritis Medications Market Size by Country (2024-2034) & (US$ Million)
Table 40. Europe Osteoarthritis Medications Market Size by Type (2018-2024) & (US$ Million)
Table 41. Europe Osteoarthritis Medications Market Size by Type (2024-2034) & (US$ Million)
Table 42. Europe Osteoarthritis Medications Market Size by Application (2018-2024) & (US$ Million)
Table 43. Europe Osteoarthritis Medications Market Size by Application (2024-2034) & (US$ Million)
Table 44. Europe Osteoarthritis Medications Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 45. Europe Osteoarthritis Medications Market Size by Country (2018-2024) & (US$ Million)
Table 46. Europe Osteoarthritis Medications Market Size by Country (2024-2034) & (US$ Million)
Table 47. China Osteoarthritis Medications Market Size by Type (2018-2024) & (US$ Million)
Table 48. China Osteoarthritis Medications Market Size by Type (2024-2034) & (US$ Million)
Table 49. China Osteoarthritis Medications Market Size by Application (2018-2024) & (US$ Million)
Table 50. China Osteoarthritis Medications Market Size by Application (2024-2034) & (US$ Million)
Table 51. Asia Osteoarthritis Medications Market Size by Type (2018-2024) & (US$ Million)
Table 52. Asia Osteoarthritis Medications Market Size by Type (2024-2034) & (US$ Million)
Table 53. Asia Osteoarthritis Medications Market Size by Application (2018-2024) & (US$ Million)
Table 54. Asia Osteoarthritis Medications Market Size by Application (2024-2034) & (US$ Million)
Table 55. Asia Osteoarthritis Medications Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 56. Asia Osteoarthritis Medications Market Size by Region (2018-2024) & (US$ Million)
Table 57. Asia Osteoarthritis Medications Market Size by Region (2024-2034) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Osteoarthritis Medications Market Size by Type (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Osteoarthritis Medications Market Size by Type (2024-2034) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Osteoarthritis Medications Market Size by Application (2018-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Osteoarthritis Medications Market Size by Application (2024-2034) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Osteoarthritis Medications Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 63. Middle East, Africa, and Latin America Osteoarthritis Medications Market Size by Country (2018-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Osteoarthritis Medications Market Size by Country (2024-2034) & (US$ Million)
Table 65. Pfizer Company Details
Table 66. Pfizer Business Overview
Table 67. Pfizer Osteoarthritis Medications Product
Table 68. Pfizer Revenue in Osteoarthritis Medications Business (2018-2024) & (US$ Million)
Table 69. Pfizer Recent Developments
Table 70. Johnson & Johnson Company Details
Table 71. Johnson & Johnson Business Overview
Table 72. Johnson & Johnson Osteoarthritis Medications Product
Table 73. Johnson & Johnson Revenue in Osteoarthritis Medications Business (2018-2024) & (US$ Million)
Table 74. Johnson & Johnson Recent Developments
Table 75. GlaxoSmithKline Company Details
Table 76. GlaxoSmithKline Business Overview
Table 77. GlaxoSmithKline Osteoarthritis Medications Product
Table 78. GlaxoSmithKline Revenue in Osteoarthritis Medications Business (2018-2024) & (US$ Million)
Table 79. GlaxoSmithKline Recent Developments
Table 80. Novartis Company Details
Table 81. Novartis Business Overview
Table 82. Novartis Osteoarthritis Medications Product
Table 83. Novartis Revenue in Osteoarthritis Medications Business (2018-2024) & (US$ Million)
Table 84. Novartis Recent Developments
Table 85. Bayer Company Details
Table 86. Bayer Business Overview
Table 87. Bayer Osteoarthritis Medications Product
Table 88. Bayer Revenue in Osteoarthritis Medications Business (2018-2024) & (US$ Million)
Table 89. Bayer Recent Developments
Table 90. Eli Lilly Company Details
Table 91. Eli Lilly Business Overview
Table 92. Eli Lilly Osteoarthritis Medications Product
Table 93. Eli Lilly Revenue in Osteoarthritis Medications Business (2018-2024) & (US$ Million)
Table 94. Eli Lilly Recent Developments
Table 95. Sanofi Company Details
Table 96. Sanofi Business Overview
Table 97. Sanofi Osteoarthritis Medications Product
Table 98. Sanofi Revenue in Osteoarthritis Medications Business (2018-2024) & (US$ Million)
Table 99. Sanofi Recent Developments
Table 100. Horizon Pharma Company Details
Table 101. Horizon Pharma Business Overview
Table 102. Horizon Pharma Osteoarthritis Medications Product
Table 103. Horizon Pharma Revenue in Osteoarthritis Medications Business (2018-2024) & (US$ Million)
Table 104. Horizon Pharma Recent Developments
Table 105. Abbott Company Details
Table 106. Abbott Business Overview
Table 107. Abbott Osteoarthritis Medications Product
Table 108. Abbott Revenue in Osteoarthritis Medications Business (2018-2024) & (US$ Million)
Table 109. Abbott Recent Developments
Table 110. Mylan Company Details
Table 111. Mylan Business Overview
Table 112. Mylan Osteoarthritis Medications Product
Table 113. Mylan Revenue in Osteoarthritis Medications Business (2018-2024) & (US$ Million)
Table 114. Mylan Recent Developments
Table 115. Daiichi Sankyo Company Details
Table 116. Daiichi Sankyo Business Overview
Table 117. Daiichi Sankyo Osteoarthritis Medications Product
Table 118. Daiichi Sankyo Revenue in Osteoarthritis Medications Business (2018-2024) & (US$ Million)
Table 119. Daiichi Sankyo Recent Developments
Table 120. TEVA Company Details
Table 121. TEVA Business Overview
Table 122. TEVA Osteoarthritis Medications Product
Table 123. TEVA Revenue in Osteoarthritis Medications Business (2018-2024) & (US$ Million)
Table 124. TEVA Recent Developments
Table 125. Almatica Pharma Company Details
Table 126. Almatica Pharma Business Overview
Table 127. Almatica Pharma Osteoarthritis Medications Product
Table 128. Almatica Pharma Revenue in Osteoarthritis Medications Business (2018-2024) & (US$ Million)
Table 129. Almatica Pharma Recent Developments
Table 130. Astellas Pharma Company Details
Table 131. Astellas Pharma Business Overview
Table 132. Astellas Pharma Osteoarthritis Medications Product
Table 133. Astellas Pharma Revenue in Osteoarthritis Medications Business (2018-2024) & (US$ Million)
Table 134. Astellas Pharma Recent Developments
Table 135. Tide Pharmaceutical Company Details
Table 136. Tide Pharmaceutical Business Overview
Table 137. Tide Pharmaceutical Osteoarthritis Medications Product
Table 138. Tide Pharmaceutical Revenue in Osteoarthritis Medications Business (2018-2024) & (US$ Million)
Table 139. Tide Pharmaceutical Recent Developments
Table 140. Iroko Pharmaceuticals Company Details
Table 141. Iroko Pharmaceuticals Business Overview
Table 142. Iroko Pharmaceuticals Osteoarthritis Medications Product
Table 143. Iroko Pharmaceuticals Revenue in Osteoarthritis Medications Business (2018-2024) & (US$ Million)
Table 144. Iroko Pharmaceuticals Recent Developments
Table 145. Hengrui Pharmaceutical Company Details
Table 146. Hengrui Pharmaceutical Business Overview
Table 147. Hengrui Pharmaceutical Osteoarthritis Medications Product
Table 148. Hengrui Pharmaceutical Revenue in Osteoarthritis Medications Business (2018-2024) & (US$ Million)
Table 149. Hengrui Pharmaceutical Recent Developments
Table 150. Abiogen Pharma Company Details
Table 151. Abiogen Pharma Business Overview
Table 152. Abiogen Pharma Osteoarthritis Medications Product
Table 153. Abiogen Pharma Revenue in Osteoarthritis Medications Business (2018-2024) & (US$ Million)
Table 154. Abiogen Pharma Recent Developments
Table 155. Flexion Therapeutics Company Details
Table 156. Flexion Therapeutics Business Overview
Table 157. Flexion Therapeutics Osteoarthritis Medications Product
Table 158. Flexion Therapeutics Revenue in Osteoarthritis Medications Business (2018-2024) & (US$ Million)
Table 159. Flexion Therapeutics Recent Developments
Table 160. Anika Therapeutics Company Details
Table 161. Anika Therapeutics Business Overview
Table 162. Anika Therapeutics Osteoarthritis Medications Product
Table 163. Anika Therapeutics Revenue in Osteoarthritis Medications Business (2018-2024) & (US$ Million)
Table 164. Anika Therapeutics Recent Developments
Table 165. Research Programs/Design for This Report
Table 166. Key Data Information from Secondary Sources
Table 167. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Osteoarthritis Medications Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 2. Global Osteoarthritis Medications Market Share by Type: 2022 VS 2034
Figure 3. NSAIDs Features
Figure 4. Corticosteroids Features
Figure 5. Hyaluronic Acid Injection Features
Figure 6. Others Features
Figure 7. Global Osteoarthritis Medications Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 8. Global Osteoarthritis Medications Market Share by Application: 2022 VS 2034
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Online Pharmacies Case Studies
Figure 12. Osteoarthritis Medications Report Years Considered
Figure 13. Global Osteoarthritis Medications Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 14. Global Osteoarthritis Medications Market Size, (US$ Million), 2018 VS 2022 VS 2034
Figure 15. Global Osteoarthritis Medications Market Share by Region: 2022 VS 2034
Figure 16. Global Osteoarthritis Medications Market Share by Players in 2022
Figure 17. Global Top Osteoarthritis Medications Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteoarthritis Medications as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Osteoarthritis Medications Revenue in 2022
Figure 19. North America Osteoarthritis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 20. North America Osteoarthritis Medications Market Share by Type (2018-2034)
Figure 21. North America Osteoarthritis Medications Market Share by Application (2018-2034)
Figure 22. North America Osteoarthritis Medications Market Share by Country (2018-2034)
Figure 23. United States Osteoarthritis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Canada Osteoarthritis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. Europe Osteoarthritis Medications Market Size YoY (2018-2034) & (US$ Million)
Figure 26. Europe Osteoarthritis Medications Market Share by Type (2018-2034)
Figure 27. Europe Osteoarthritis Medications Market Share by Application (2018-2034)
Figure 28. Europe Osteoarthritis Medications Market Share by Country (2018-2034)
Figure 29. Germany Osteoarthritis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. France Osteoarthritis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. U.K. Osteoarthritis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Italy Osteoarthritis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Russia Osteoarthritis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Nordic Countries Osteoarthritis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. China Osteoarthritis Medications Market Size YoY (2018-2034) & (US$ Million)
Figure 36. China Osteoarthritis Medications Market Share by Type (2018-2034)
Figure 37. China Osteoarthritis Medications Market Share by Application (2018-2034)
Figure 38. Asia Osteoarthritis Medications Market Size YoY (2018-2034) & (US$ Million)
Figure 39. Asia Osteoarthritis Medications Market Share by Type (2018-2034)
Figure 40. Asia Osteoarthritis Medications Market Share by Application (2018-2034)
Figure 41. Asia Osteoarthritis Medications Market Share by Region (2018-2034)
Figure 42. Japan Osteoarthritis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. South Korea Osteoarthritis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. China Taiwan Osteoarthritis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Southeast Asia Osteoarthritis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. India Osteoarthritis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Australia Osteoarthritis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Osteoarthritis Medications Market Size YoY (2018-2034) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Osteoarthritis Medications Market Share by Type (2018-2034)
Figure 50. Middle East, Africa, and Latin America Osteoarthritis Medications Market Share by Application (2018-2034)
Figure 51. Middle East, Africa, and Latin America Osteoarthritis Medications Market Share by Country (2018-2034)
Figure 52. Brazil Osteoarthritis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 53. Mexico Osteoarthritis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 54. Turkey Osteoarthritis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 55. Saudi Arabia Osteoarthritis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 56. Israel Osteoarthritis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 57. GCC Countries Osteoarthritis Medications Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 58. Pfizer Revenue Growth Rate in Osteoarthritis Medications Business (2018-2024)
Figure 59. Johnson & Johnson Revenue Growth Rate in Osteoarthritis Medications Business (2018-2024)
Figure 60. GlaxoSmithKline Revenue Growth Rate in Osteoarthritis Medications Business (2018-2024)
Figure 61. Novartis Revenue Growth Rate in Osteoarthritis Medications Business (2018-2024)
Figure 62. Bayer Revenue Growth Rate in Osteoarthritis Medications Business (2018-2024)
Figure 63. Eli Lilly Revenue Growth Rate in Osteoarthritis Medications Business (2018-2024)
Figure 64. Sanofi Revenue Growth Rate in Osteoarthritis Medications Business (2018-2024)
Figure 65. Horizon Pharma Revenue Growth Rate in Osteoarthritis Medications Business (2018-2024)
Figure 66. Abbott Revenue Growth Rate in Osteoarthritis Medications Business (2018-2024)
Figure 67. Mylan Revenue Growth Rate in Osteoarthritis Medications Business (2018-2024)
Figure 68. Daiichi Sankyo Revenue Growth Rate in Osteoarthritis Medications Business (2018-2024)
Figure 69. TEVA Revenue Growth Rate in Osteoarthritis Medications Business (2018-2024)
Figure 70. Almatica Pharma Revenue Growth Rate in Osteoarthritis Medications Business (2018-2024)
Figure 71. Astellas Pharma Revenue Growth Rate in Osteoarthritis Medications Business (2018-2024)
Figure 72. Tide Pharmaceutical Revenue Growth Rate in Osteoarthritis Medications Business (2018-2024)
Figure 73. Iroko Pharmaceuticals Revenue Growth Rate in Osteoarthritis Medications Business (2018-2024)
Figure 74. Hengrui Pharmaceutical Revenue Growth Rate in Osteoarthritis Medications Business (2018-2024)
Figure 75. Abiogen Pharma Revenue Growth Rate in Osteoarthritis Medications Business (2018-2024)
Figure 76. Flexion Therapeutics Revenue Growth Rate in Osteoarthritis Medications Business (2018-2024)
Figure 77. Anika Therapeutics Revenue Growth Rate in Osteoarthritis Medications Business (2018-2024)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries